ELECTROMED INC (ELMD) Stock Fundamental Analysis

USA • NYSE Arca • NYSEARCA:ELMD • US2854091087

29 USD
-0.23 (-0.79%)
At close: Feb 5, 2026
29 USD
0 (0%)
After Hours: 2/5/2026, 8:22:00 PM
Fundamental Rating

7

ELMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. ELMD gets an excellent profitability rating and is at the same time showing great financial health properties. ELMD has a decent growth rate and is not valued too expensively. This makes ELMD very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year ELMD was profitable.
  • In the past year ELMD had a positive cash flow from operations.
  • In the past 5 years ELMD has always been profitable.
  • ELMD had a positive operating cash flow in 4 of the past 5 years.
ELMD Yearly Net Income VS EBIT VS OCF VS FCFELMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 14.01%, ELMD belongs to the top of the industry, outperforming 95.70% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 17.44%, ELMD belongs to the top of the industry, outperforming 93.01% of the companies in the same industry.
  • ELMD has a Return On Invested Capital of 16.69%. This is amongst the best in the industry. ELMD outperforms 96.77% of its industry peers.
  • ELMD had an Average Return On Invested Capital over the past 3 years of 11.76%. This is above the industry average of 8.80%.
  • The 3 year average ROIC (11.76%) for ELMD is below the current ROIC(16.69%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.01%
ROE 17.44%
ROIC 16.69%
ROA(3y)10.26%
ROA(5y)8.54%
ROE(3y)12.47%
ROE(5y)10.29%
ROIC(3y)11.76%
ROIC(5y)9.74%
ELMD Yearly ROA, ROE, ROICELMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 11.78%, ELMD belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
  • ELMD's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 15.43%, ELMD belongs to the top of the industry, outperforming 84.41% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ELMD has grown nicely.
  • The Gross Margin of ELMD (78.08%) is better than 90.32% of its industry peers.
  • In the last couple of years the Gross Margin of ELMD has remained more or less at the same level.
Industry RankSector Rank
OM 15.43%
PM (TTM) 11.78%
GM 78.08%
OM growth 3Y29.31%
OM growth 5Y3.56%
PM growth 3Y28.63%
PM growth 5Y-1.68%
GM growth 3Y1.14%
GM growth 5Y0.12%
ELMD Yearly Profit, Operating, Gross MarginsELMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ELMD is still creating some value.
  • ELMD has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ELMD has been reduced compared to 5 years ago.
  • There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ELMD Yearly Shares OutstandingELMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ELMD Yearly Total Debt VS Total AssetsELMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 16.82 indicates that ELMD is not in any danger for bankruptcy at the moment.
  • ELMD's Altman-Z score of 16.82 is amongst the best of the industry. ELMD outperforms 95.16% of its industry peers.
  • There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.82
ROIC/WACC1.64
WACC10.17%
ELMD Yearly LT Debt VS Equity VS FCFELMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 4.31 indicates that ELMD has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 4.31, ELMD is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • ELMD has a Quick Ratio of 3.99. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ELMD (3.99) is better than 75.27% of its industry peers.
Industry RankSector Rank
Current Ratio 4.31
Quick Ratio 3.99
ELMD Yearly Current Assets VS Current LiabilitesELMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ELMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.17%, which is quite impressive.
  • ELMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.82% yearly.
  • Looking at the last year, ELMD shows a quite strong growth in Revenue. The Revenue has grown by 16.97% in the last year.
  • Measured over the past years, ELMD shows a quite strong growth in Revenue. The Revenue has been growing by 14.53% on average per year.
EPS 1Y (TTM)29.17%
EPS 3Y47.61%
EPS 5Y17.82%
EPS Q2Q%56.25%
Revenue 1Y (TTM)16.97%
Revenue growth 3Y15.39%
Revenue growth 5Y14.53%
Sales Q2Q%15.13%

3.2 Future

  • Based on estimates for the next years, ELMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.13% on average per year.
  • The Revenue is expected to grow by 9.48% on average over the next years. This is quite good.
EPS Next Y28.75%
EPS Next 2Y26.7%
EPS Next 3Y10.13%
EPS Next 5YN/A
Revenue Next Year13.84%
Revenue Next 2Y12.69%
Revenue Next 3Y9.48%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ELMD Yearly Revenue VS EstimatesELMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
ELMD Yearly EPS VS EstimatesELMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 31.18, ELMD can be considered very expensive at the moment.
  • 73.66% of the companies in the same industry are more expensive than ELMD, based on the Price/Earnings ratio.
  • ELMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 21.51, the valuation of ELMD can be described as rather expensive.
  • 79.03% of the companies in the same industry are more expensive than ELMD, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. ELMD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 31.18
Fwd PE 21.51
ELMD Price Earnings VS Forward Price EarningsELMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ELMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ELMD is cheaper than 74.73% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ELMD is valued cheaply inside the industry as 88.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.81
EV/EBITDA 20.52
ELMD Per share dataELMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ELMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.08
PEG (5Y)1.75
EPS Next 2Y26.7%
EPS Next 3Y10.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ELMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ELECTROMED INC

NYSEARCA:ELMD (2/5/2026, 8:22:00 PM)

After market: 29 0 (0%)

29

-0.23 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)02-10
Inst Owners51.92%
Inst Owner Change3.08%
Ins Owners8.11%
Ins Owner Change3.36%
Market Cap241.86M
Revenue(TTM)64.00M
Net Income(TTM)7.54M
Analysts82
Price Target36.72 (26.62%)
Short Float %2.97%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.03%
Min EPS beat(2)2.94%
Max EPS beat(2)13.12%
EPS beat(4)4
Avg EPS beat(4)114.69%
Min EPS beat(4)2.94%
Max EPS beat(4)422.88%
EPS beat(8)7
Avg EPS beat(8)66.61%
EPS beat(12)9
Avg EPS beat(12)56.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)2.49%
Revenue beat(4)3
Avg Revenue beat(4)2.7%
Min Revenue beat(4)-2.37%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)6
Avg Revenue beat(12)0.71%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)7.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 31.18
Fwd PE 21.51
P/S 3.78
P/FCF 21.81
P/OCF 21.23
P/B 5.6
P/tB 5.65
EV/EBITDA 20.52
EPS(TTM)0.93
EY3.21%
EPS(NY)1.35
Fwd EY4.65%
FCF(TTM)1.33
FCFY4.58%
OCF(TTM)1.37
OCFY4.71%
SpS7.67
BVpS5.18
TBVpS5.14
PEG (NY)1.08
PEG (5Y)1.75
Graham Number10.41
Profitability
Industry RankSector Rank
ROA 14.01%
ROE 17.44%
ROCE 22.78%
ROIC 16.69%
ROICexc 25.78%
ROICexgc 26.13%
OM 15.43%
PM (TTM) 11.78%
GM 78.08%
FCFM 17.32%
ROA(3y)10.26%
ROA(5y)8.54%
ROE(3y)12.47%
ROE(5y)10.29%
ROIC(3y)11.76%
ROIC(5y)9.74%
ROICexc(3y)17.46%
ROICexc(5y)14.38%
ROICexgc(3y)18.08%
ROICexgc(5y)14.87%
ROCE(3y)16.06%
ROCE(5y)13.3%
ROICexgc growth 3Y46.82%
ROICexgc growth 5Y11%
ROICexc growth 3Y45.6%
ROICexc growth 5Y10.61%
OM growth 3Y29.31%
OM growth 5Y3.56%
PM growth 3Y28.63%
PM growth 5Y-1.68%
GM growth 3Y1.14%
GM growth 5Y0.12%
F-Score8
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 26.11%
Cap/Sales 0.48%
Interest Coverage 250
Cash Conversion 103.16%
Profit Quality 147.1%
Current Ratio 4.31
Quick Ratio 3.99
Altman-Z 16.82
F-Score8
WACC10.17%
ROIC/WACC1.64
Cap/Depr(3y)117.67%
Cap/Depr(5y)133.86%
Cap/Sales(3y)1.59%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.17%
EPS 3Y47.61%
EPS 5Y17.82%
EPS Q2Q%56.25%
EPS Next Y28.75%
EPS Next 2Y26.7%
EPS Next 3Y10.13%
EPS Next 5YN/A
Revenue 1Y (TTM)16.97%
Revenue growth 3Y15.39%
Revenue growth 5Y14.53%
Sales Q2Q%15.13%
Revenue Next Year13.84%
Revenue Next 2Y12.69%
Revenue Next 3Y9.48%
Revenue Next 5YN/A
EBIT growth 1Y50.01%
EBIT growth 3Y49.21%
EBIT growth 5Y18.61%
EBIT Next Year79.36%
EBIT Next 3Y12.1%
EBIT Next 5YN/A
FCF growth 1Y27.85%
FCF growth 3YN/A
FCF growth 5Y28.06%
OCF growth 1Y25.65%
OCF growth 3YN/A
OCF growth 5Y22.11%

ELECTROMED INC / ELMD FAQ

What is the ChartMill fundamental rating of ELECTROMED INC (ELMD) stock?

ChartMill assigns a fundamental rating of 7 / 10 to ELMD.


What is the valuation status for ELMD stock?

ChartMill assigns a valuation rating of 5 / 10 to ELECTROMED INC (ELMD). This can be considered as Fairly Valued.


How profitable is ELECTROMED INC (ELMD) stock?

ELECTROMED INC (ELMD) has a profitability rating of 8 / 10.


What is the financial health of ELECTROMED INC (ELMD) stock?

The financial health rating of ELECTROMED INC (ELMD) is 9 / 10.


What is the expected EPS growth for ELECTROMED INC (ELMD) stock?

The Earnings per Share (EPS) of ELECTROMED INC (ELMD) is expected to grow by 28.75% in the next year.